A Gene Editing Breakthrough
By Tom Ashbrook,
NPR On Point [features Marcy Darnovsky]
| 08. 08. 2017
After the blockbuster announcement a U.S. team successfully edited human embryos come the tough medical and ethical questions. We’ll talk it through.
A first in the U.S.: researchers have now edited the genetic code of viable human embryos, cutting and splicing to avoid defect and disease. The DNA of human embryos. Genetically edited. The edited embryos weren’t implanted in a woman. Weren’t born. But they could have been. New life spared disease, maybe death. How far does this gene editing go? How fast? For whom? And for, or against, what human traits? This hour On Point: editing the code of human life. -- Tom Ashbrook
Guests
Amy Dockser Marcus, health and science reporter for the Wall Street Journal. (@AmyDMarcus)
Dr. Paula Amato, co-author of the study showing successful editing of genes in human embryos. Associate professor of obstetrics and gynecology at Oregon Health & Science University.
Arthur Caplan, professor of bioethics and head of the division of medical ethics at the New York University School of Medicine. (@ArthurCaplan)
Marcy Darnovsky, executive director of...
Related Articles
By Danny Finley, Bill of Health | 01.08.2026
The United States Food and Drug Administration (FDA) has a unique funding structure among federal scientific and health agencies. The industries it regulates fund nearly half of its budget. The agency charges companies a user fee for each application
...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...
By Nick Paul Taylor, Fierce Biotech | 01.09.2026
Menlo Ventures has made a $16 million bet that the “baby KJ” custom CRISPR therapy success story is repeatable. The funding has enabled CRISPR co-inventor Jennifer Doudna, Ph.D., and baby KJ scientist Fyodor Urnov, Ph.D., to launch Aurora...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...